SAS Programmer II

Job Description:

SAS Programmer II

Working under the direction of the Biostatistician, senior-level SAS Programmer and/or Manager, the SAS Programmer II aids programming activities for various purposes including CSRs, DSMBs, interim analyses, manuscripts, etc. Mainly supports statistical programming of statistical analysis plan (SAP)-planned tables, data listings, and graphs for CSRs, as well as integrated summaries of safety and efficacy, ad hoc analyses and electronic submission deliverables, such as datasets, data documentation, programs, programming table of contents, and patient profiles.

In addition, the SAS Programmer II supports migration activities in the creation of Standard Data Tabulation Model (SDTM) and production of the Analysis Data Model (ADaM).

Make an Impact at Veristat!

Join a global team with more than 30 years of expertise accelerating life-changing therapies to patients worldwide.

• 105+ approved therapies for marketing applications prepared by Veristat
• 480+ oncology projects in the past 5 years
• 350+ rare disease projects delivered in the past 5 years
• Flexible, inclusive culture — 70% remote workforce, 66% women-led teams
• Learn more about our core values here!

What we look for:

• Bachelor’s Degree in technology, statistics, pharmaceutics or another related science or mathematics field with a minimum of 4 years of SAS programming experience with clinical trial data OR a Master’s Degree in technology, statistics, pharmaceutics or another related science or mathematics field with a minimum of 3 years of SAS programming experience with clinical trial data.
• Good working knowledge of CDISC SDTM Implementation Guidelines.
• Good working knowledge of CDISC ADaM Implementation Guidelines.
• General knowledge of regulatory requirements and drug development process.
• Excellent organizational skills and good verbal and written communication skills.
• Ability to work independently as well as collaborate with teams is required.
• Strong communication skill set with peers and business partners.
• Strong data analysis skills.
• Leadership skills to lead project team to deliver high quality deliverables on time.
• Must be fluent in English (written and verbal).

Automated Decision Making: All applicants are reviewed by a member of the Veristat Talent Acquisition team; Veristat does not utilize an automated decision-making process.

Equal Opportunity Employer

Veristat is proud to provide exceptional services to our clients, assisting in the successful development of innovations that improve and save lives. We are equally proud to recruit, develop and retain the best and the brightest talent across a variety of business functions to make that happen. We are an Equal Opportunity Employer that values the strength and creativity that diversity brings to our workplace.

Veristat provides equal employment opportunities to all employees and applicants for employment without regard to age, disability, genetics, gender identity or expression, gender reassignment (i.e., transgender status), marriage and civil partnership, pregnancy and maternity, race (including color, nationality, and ethnic or national origins), religion or belief, sex or sexual orientation, physical appearance, veteran status, source of income, arrest or conviction record or any other category protected under characteristics considered unlawful in any circumstances of employment offers and practices.

Reasonable Accommodations

Veristat is dedicated to providing an accessible and inclusive application experience for all candidates.

If you require a reasonable accommodation to complete your application, participate in an assessment, or attend an interview, please contact our Talent Acquisition team at talentacquisition@veristat.com or +437 886 8063. We will work with you to meet your needs, ensuring a fair process. All requests in relation to your application will be treated confidentially.

For more information about how we collect and store your personal data during the hiring process, please see our Career Recruitment Notice